Login / Signup

Kidney outcomes of SGLT2 inhibitors among older patients with diabetic kidney disease in real-world clinical practice: the Japan Chronic Kidney Disease Database Ex.

Kaori KitaokaYuichiro YanoHajime NagasuHiroshi KanegaeNoriharu ChishimaHiroki AkiyamaKouichi TamuraNaoki Kashihara
Published in: BMJ open diabetes research & care (2024)
The benefits of SGLT2 inhibitors on renal outcomes are also applicable to older patients with DKD aged≥75 years.
Keyphrases
  • chronic kidney disease
  • clinical practice
  • end stage renal disease
  • type diabetes
  • community dwelling
  • peritoneal dialysis
  • adverse drug